genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2011
Prognosis
Cancer
Researchers Find Healthy Breast Tissue Secretes IL-25 to Kill Tumor Cells
Cancer
FDA Clears Rituxan as Maintenance Therapy for Advanced Follicular Lymphoma
Cancer
Tumor Suppressor Found to Act as Oncogene in Glioblastoma
Cancer
Roche Claims Phase III Data Supports Use of Avastin in Ovarian Cancer
Insights
Gene-Expression Profiling Goes Solo
Cancer
Gene Expression Based Prognostic Signatures in Lung Cancer Not Ready for Clinical Use
Drug Discovery
INC Research to Offer invivodata ePRO Solutions
Cancer
Researchers Provide New Evidence for Role of FGFR1 Amplification in Tamoxifen Resistance
News
Quintiles and Invivodata Join Forces to Offer ePRO Solutions
Podcasts
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS
1
...
5
6
7
8
Page 6 of 8
Scroll Up
Scroll Up
